The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly 52,000 will die from the disease.

The problem with pancreatic cancer is that we often catch it too late,” he stated. The PAC-MANN test aims to enable clinicians to detect the disease at an earlier stage when

Researchers have developed a simple blood test to detect pancreatic cancer before it spreads to other sites in the body. The test could be used for routine screening to improve the disease’s low survival rate 1.

OHSU's PAC-MANN test offers a breakthrough in pancreatic cancer detection, using a small blood sample to monitor protease activity with high accuracy.